Kamunting Street Capital Management’s Merck MRK Stock Holding History

Kamunting Street Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50,000	Closed	-$4.2M	–	20
2025 Q3	$4.2M	Buy	50,000 +34,590	+224%	+$2.85M	3.12%	8
2025 Q2	$1.22M	Buy	+15,410	New	+$1.22M	1%	12
2024 Q1	–	Sell	-2,738	Closed	-$298K	–	20
2023 Q4	$298K	Sell	2,738 -27,262	-91%	-$2.83M	0.37%	18
2023 Q3	$3.09M	Buy	+30,000	New	+$3.23M	2.34%	15
2018 Q3	–	Sell	-52,400	Closed	-$3.04M	–	24
2018 Q2	$3.04M	Sell	52,400 -39,824	-43%	-$2.25M	4.19%	9
2018 Q1	$4.79M	Hold	92,224	–	–	3.77%	7
2017 Q4	$4.95M	Buy	92,224 +55,544	+151%	+$3.08M	3.52%	8
2017 Q3	$2.24M	Buy	+36,680	New	+$2.22M	1.42%	13

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kamunting Street Capital Management's MRK Position: Q4 2025 in Review

Kamunting Street Capital Management sold out of Merck (MRK) in Q4 2025, closing a stake of 50,000 shares — an estimated $4.2M sold.

Kamunting Street Capital Management first reported a position in MRK in Q3 2017 and held it in 8 quarters. The position peaked at $4.95M in Q4 2017. 3,656 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

Kamunting Street Capital Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
Kamunting Street Capital Management sold 50,000 Merck shares in Q4 2025, an estimated $4.2M.
Kamunting Street Capital Management first reported a position in Merck in Q3 2017 and held it in 8 quarters.
Kamunting Street Capital Management's Merck position peaked at $4.95M in Q4 2017.
3,656 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Kamunting Street Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.